Camila Vazquez Echegaray

Mrs. Camila Vazquez Echegaray

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
RSRita Silvério-Alves
Rita Silvério-Alves
IKIlia Kurochkin
Ilia Kurochkin
ARAnna Rydström
Anna Rydström
CECamila Vazquez Echegaray
Camila Vazquez Echegaray
JHJakob Haider
Jakob Haider
CPCarlos-Filipe Pereira
Carlos-Filipe Pereira
In mitosis, most transcription factors detach from chromatin, but some are retained and bookmark genomic sites. Mitotic bookmarking has been implicated in lineage inheritance, pluripotency and reprogramming. However, the biological significance of this mechanism in vivo remains unclear. Here, we address mitotic retention of the hemogenic factors GATA2, GFI1B and FOS during haematopoietic specification. We show that GATA2 remains bound to chromatin throughout mitosis, in contrast to GFI1B and FOS, via C-terminal zinc finger-mediated DNA binding. GATA2 bookmarks a subset of its interphase targets that are co-enriched for RUNX1 and other regulators of definitive haematopoiesis. Remarkably, homozygous mice harbouring the cyclin B1 mitosis degradation domain upstream Gata2 partially phenocopy knockout mice. Degradation of GATA2 at mitotic exit abolishes definitive haematopoiesis at aorta-gonad-mesonephros, placenta and foetal liver, but does not impair yolk sac haematopoiesis. Our findings implicate GATA2-mediated mitotic bookmarking as critical for definitive haematopoiesis and highlight a dependency on bookmarkers for lineage commitment.

1 April 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
CSClaudia Solari
Claudia Solari
CECamila Vazquez Echegaray
Camila Vazquez Echegaray
CLCarlos Luzzani
Carlos Luzzani
MCMaría Soledad Cosentino
María Soledad Cosentino
AWAriel Waisman
Ariel Waisman
AGAlejandra S Guberman
Alejandra S Guberman

29 December 2020 in Cells
Verified
Journal Article
Open access
PDF file
ATAyelén Toro
Ayelén Toro
NANicolas Anselmino
Nicolas Anselmino
CSClaudia Solari
Claudia Solari
MFMarcos Francia
Marcos Francia
COCamila Oses
Camila Oses
AGAlejandra S Guberman
Alejandra S Guberman
Stem cells genome safeguarding requires strict oxidative stress control. Heme oxygenase-1 (HO-1) and p53 are relevant components of the cellular defense system. p53 controls cellular response to multiple types of harmful stimulus, including oxidative stress. Otherwise, besides having a protective role, HO-1 is also involved in embryo development and in embryonic stem (ES) cells differentiation. Although both proteins have been extensively studied, little is known about their relationship in stem cells. The aim of this work is to explore HO-1-p53 interplay in ES cells. We studied HO-1 expression in p53 knockout (KO) ES cells and we found that they have higher HO-1 protein levels but similar HO-1 mRNA levels than the wild type (WT) ES cell line. Furthermore, cycloheximide treatment increased HO-1 abundance in p53 KO cells suggesting that p53 modulates HO-1 protein stability. Notably, H2O2 treatment did not induce HO-1 expression in p53 KO ES cells. Finally, SOD2 protein levels are also increased while Sod2 transcripts are not in KO cells, further suggesting that the p53 null phenotype is associated with a reinforcement of the antioxidant machinery. Our results demonstrate the existence of a connection between p53 and HO-1 in ES cells, highlighting the relationship between these stress defense pathways.

1 July 2019 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
CSClaudia Solari
Claudia Solari
MPMaría Victoria Petrone
María Victoria Petrone
ATAyelén Toro
Ayelén Toro
CECamila Vazquez Echegaray
Camila Vazquez Echegaray
MCMaría Soledad Cosentino
María Soledad Cosentino
AGAlejandra S Guberman
Alejandra S Guberman
Redox homeostasis maintenance is essential to bring about cellular functions. Particularly, embryonic stem cells (ESCs) have high fidelity mechanisms for DNA repair, high activity of different antioxidant enzymes and low levels of oxidative stress. Although the expression and activity of antioxidant enzymes are reduced throughout the differentiation, the knowledge about the transcriptional regulation of genes involved in defense against oxidative stress is yet restricted. Since glutathione is a central component of a complex system involved in preserving cellular redox status, we aimed to study whether the expression of the glutathione reductase (Gsr) gene, which encodes an essential enzyme for cellular redox homeostasis, is modulated by the transcription factors critical for self-renewal and pluripotency of ESCs. We found that Gsr gene is expressed in ESCs during the pluripotent state and it was upregulated when these cells were induced to differentiate, concomitantly with Nanog decreased expression. Moreover, we found an increase in Gsr mRNA levels when Nanog was downregulated by a specific shRNA targeting this transcription factor in ESCs. Our results suggest that Nanog represses Gsr gene expression in ESCs, evidencing a role of this crucial pluripotency transcription factor in preservation of redox homeostasis in stem cells.

11 December 2023 in Development
Verified
Journal Article
Open access
PDF file
HLHsiu-Chuan Lin
Hsiu-Chuan Lin
AMAly Makhlouf
Aly Makhlouf
CECamila Vazquez Echegaray
Camila Vazquez Echegaray
DZDorota Zawada
Dorota Zawada
FSFilipa Simões
Filipa Simões
In recent years, there have been notable advancements in the ability to programme human cell identity, enabling us to design and manipulate cell function in a Petri dish. However, current protocols for generating target cell types often lack efficiency and precision, resulting in engineered cells that do not fully replicate the desired identity or functional output. This applies to different methods of cell programming, which face similar challenges that hinder progress and delay the achievement of a more favourable outcome. However, recent technological and analytical breakthroughs have provided us with unprecedented opportunities to advance the way we programme cell fate. The Company of Biologists’ 2023 workshop on ‘Novel Technologies for Programming Human Cell Fate’ brought together experts in human cell fate engineering and experts in single-cell genomics, manipulation and characterisation of cells on a single (sub)cellular level. Here, we summarise the main points that emerged during the workshop's themed discussions. Furthermore, we provide specific examples highlighting the current state of the field as well as its trajectory, offering insights into the potential outcomes resulting from the application of these breakthrough technologies in precisely engineering the identity and function of clinically valuable human cells.

1 August 2023 in Cellular Reprogramming
Verified
Journal Article
Closed access
CECamila Vazquez Echegaray
Camila Vazquez Echegaray
In the era of stem cell research and regenerative medicine, understanding the regulatory networks that drive cellular reprogramming is fundamental. The study entitled “Cross-lineage potential of Ascl1 uncovered by comparing diverse reprogramming regulatomes” published in Stem Cell Reports sheds light on the remarkable versatility of Ascl1, a transcription factor known for its pivotal role in neurogenesis. By comparing regulatomes across multiple cell lineages, the authors have elucidated the potential of Ascl1 to facilitate the conversion of non-neural cells into various lineages beyond its canonical neural fate, suggesting its potential as a master regulator for lineage reprogramming. These observations challenge our current understanding of cell fate determination and open exciting avenues for regenerative medicine.